Navigation Links
Inhaled Steriods Used as Preventive Treatment Post 9/11
Date:10/24/2007

Popular Asthma Medication Linked to Respiratory Improvement in NYC

Firefighters

CHICAGO, Oct. 24 /PRNewswire/ -- Inhaled corticosteroids (ICS), antiinflammatory treatments often prescribed for asthma, may be beneficial in preventing respiratory illness, according to a new study. The research, presented at CHEST 2007, the 73rd annual international scientific assembly of the American College of Chest Physicians (ACCP), examined the effectiveness of ICS in preventing asthma and other respiratory illness due to inhalation exposures experienced by NYC firefighters after the World Trade Center (WTC) collapse. Two years post-collapse, those firefighters treated with ICS reported positive feedback.

"Respiratory protection is often needed during disasters, but it is difficult to get it instantly, and many responders, without EMS or fire experience, have not been trained or fit-tested to wear equipment properly. Couple this with a disaster environment that is difficult in which to function, and it leads to exposures that could result in lung damage," said study author David Prezant, MD, FCCP, Chief Medical Officer, Office of Medical Affairs and Co-Director WTC Medical Monitoring and Treatment Programs, New York City Fire Department. "However, our preliminary data suggest that combining prophylactic inhaled corticosteroids with our best attempts to provide proper respiratory protection could reduce declines in lung function."

One week post-WTC attack, Dr. Prezant and his colleagues from the New York City Fire Department offered ICS to NYC firefighters. Participating firefighters were told to use the ICS inhaler daily for 4 weeks. Two years post-WTC collapse, Dr. Prezant and coinvestigators from Montefiore Medical Center, New York University College of Medicine, and the Shaare Zedek Medical Center in Israel, offered free, voluntary evaluations of respiratory symptoms and function to the treated firefighters and a comp
'/>"/>

SOURCE American College of Chest Physicians
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
2. PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin
3. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
4. Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference
5. Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
6. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
7. Point of Care Strep Tests Speed Treatment, Lower Costs
8. Rapid HIV Testing Increases Possibility of Treatment
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...uly 24 /- Alexza,Pharmaceut...it has initiated,its second Phase 3 clinical trial...inhalation product candidate being developed for t...chizophrenia or bipolar disorder.,Alexza believes ...inetic,(PK) properties resulting from inhaled loxa...
(Date:7/24/2008)...Program Speeds Oncology Patient Accrual, DENVER, ...ch Management,Organization (RMO), has contracted w...de research and site management services for their...llment strategy. The new,trials include the follow...Lymphoma, Metastatic Breast Cancer, Metastatic Sar...
(Date:7/24/2008)..., July 24 /- NicOx S.A.,(Eu...sults from the 52-week,open label safety extension...e 301 phase 3 study for naproxcinod. The results r... was maintained for the one-year duration of,the s...nt scale. In,addition, the results showed that the...
(Date:7/23/2008)...wire/ -- Sound Pharmaceuticals (SPI) has filed,an ...for the clinical,testing of a proprietary formulat...induced hearing loss or ototoxicity. The oral caps...n advanced stage lung cancer,and head and neck can....,This marks the second development program for SP...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2K State Preparing to Share Expertise With Bioscientists 3601 1K State Preparing to Share Expertise With Bioscientists 3601 24th annual Templeton Cambridge fellowships awarded to 10 noted journalists 13054 14th annual Templeton Cambridge fellowships awarded to 10 noted journalists 13054 24th annual Templeton Cambridge fellowships awarded to 10 noted journalists 13054 34th annual Templeton Cambridge fellowships awarded to 10 noted journalists 13054 4Emeril Lagasse and Planet Green Partner with Whole Foods Market 28R 29 on Innovative New Series 13051 1Emeril Lagasse and Planet Green Partner with Whole Foods Market 28R 29 on Innovative New Series 13051 2Emeril Lagasse and Planet Green Partner with Whole Foods Market 28R 29 on Innovative New Series 13051 3Ginkgo Biloba Might Not Preserve Memory in Octogenarians 13049 1Ginkgo Biloba Might Not Preserve Memory in Octogenarians 13049 2Ginkgo Biloba Might Not Preserve Memory in Octogenarians 13049 3
...GLE PARK, N.C. & SHERBROOKE, Quebec--(BUSINESS...biopharmaceutical,company developing small molecul...metabolic diseases, today announced positive,resul...lerating,gastric emptying in diabetic patients wit...tudy were presented at the American,Diabetes Assoc...
...technology Company updates progress and upcoming,m...26, 2007 /PRNewswire-FirstCall/ - SemBioSys,Geneti...tfolio of,therapeutic proteins for metabolic and c...eclinical data supporting the,development of plant...esented its findings at the 67th Scientific Sessio...
Other Medicine Technology:Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4
(Date:7/25/2008)... Though the number of jobs created in the me...es reported a different kind of slowdown: they lai.... , Seattle, WA (PRWEB) J...in the medical field slowed in June overall, pharm...lowdown that will be music to the ears of sales re...
(Date:7/25/2008)...rporation Executive, Robert J. Reilly, Joins Aetho...n Inc.,( http://www.aethon.com ), the leading deve... logistics, today announced that Robert J. Reilly ... Chief Financial Officer., Reilly, who was most r...sson Corporation,s Specialty Pharmacy Division, br...
(Date:7/25/2008)...ack-up in esophagus can cause immune system change...- The first evidence linking gastroesophageal refl...y Duke University Medical Center researchers. ,...st noted in the 1970s, and since then studies have...sthma patients also experience GERD symptoms. But ...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:People With GERD More Likely to Develop Asthma 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3
...Researchers have uncovered important information a...zed DNA, a critical step in DNA mutation that has ...at appears in the August edition of the Journal of... Georgia Institute of Technology have reported unc...
...The cells and receptors responsible for sour taste...titute researcher Charles S. Zuker and Nicholas J....er seven years of working together to identify the...r three of the five tastes humans can sense -- swe...
...Aromatherapy, the treatment using scents, is one o...ne. It is a holistic treatment of caring for the ...t is widely used at home, clinics and hospitals fo...in relief for women in labor pain, relieving pain ...
...The Beijing Health Bureau confirmed on Friday the .... About 3,142 HIV carriers and AIDS patients were...ing according to Statistics from the Beijing Healt...re discovered in the first six months of the year....
Other Medicine News:Health News:Elusive Step In DNA Mutation Uncovered By Researchers 2Health News:Elusive Step In DNA Mutation Uncovered By Researchers 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 4Health News:Sour Taste Sensors Identified 2Health News:Sour Taste Sensors Identified 3Health News:Benefits Of Aromatherapy 2Health News:Benefits Of Aromatherapy 3Health News:Benefits Of Aromatherapy 4
Portable Compressor Nebulizer
The 50 psi MaxiCompressor, the workhorse of compressors, is designed to run 24 hours a day, 7 days a week. It features a tamper-proof locking regulator valve to guard against unintentional increases
The 45 PSI SuperSportNeb provides superior performance that translates to shorter treatment times. Like the SportNeb, it is constructed with die-cast aluminum compressor components for consistent rel
The very popular and competitively priced SportNeb features a 35 PSI, die-cast aluminum compressor. Design enhancements include a neb kit holder, built-in cord storage and optional black carry bag. T
Medicine Products: